News

Clinicians consider administration of human papillomavirus (HPV) vaccine as feasible at age 9 to 10 years, and parents appear to be receptive to discussing vaccination at this age, according to a ...
One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck’s Gardasil vaccine, court ...
As per data from the ICO/IARC Information Centre (2023), India has 1.23 lakh active cervical cancer cases and over 77,000 annual deaths. Nearly 511.4 million women aged 15 years and above are at risk.
China’s first domestically developed nine-valent human papillomavirus (HPV) vaccine has been approved for marketing by the National Medical Products Administration, breaking the more than decade ...
HPV is a sexually transmitted infection primarily spread through skin-to-skin contact. Although approximately 5 percent of cases may have a hereditary component, the main cause of HPV-related issues ...
Pakistan, June 14 -- Pakistan's southern Sindh province will launch a Human Papillomavirus (HPV) vaccination drive for school-going girls aged nine to 14 years in September, state-run media ...
This article reviews the history and future of the HPV vaccine. ... As of 2007 we stand with two successful commercial prophylactic vaccines that efficiently ... vaccines. Gardasil ® (Merck) and ...
Learn more about HPV self-collection, a step closer to eliminating cervical cancer, and its importance in early detection and prevention. Find out how this simple test can save lives.
Cost, Distribution & Stability of HPV L1 VLP Vaccines; ... (VLP) vaccines. Gardasil ® (Merck) and Cervarix ® (GSK) have been positively evaluated in women up to 55 years of age.
With 272 miles of range and more room inside its walls than your first apartment, GM’s Chevy Brightdrop electric van is one of the best commercial EVs you can buy.
Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion.